Dr Ben James Lawrence

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.
  • Heatlie, J., Chang, V., Fitzgerald, S., Nursalim, Y., Parker, K., Lawrence, B., ... Blenkiron, C. (2020). Specialized Cell-Free DNA Blood Collection Tubes Can Be Repurposed for Extracellular Vesicle Isolation: A Pilot Study. Biopreservation and biobanking, 18 (5), 462-470. 10.1089/bio.2020.0060
    Other University of Auckland co-authors: Cherie Blenkiron, Yohanes Nursalim, Sandra Fitzgerald
  • Singh, S., Bergsland, E. K., Card, C. M., Hope, T. A., Kunz, P. L., Laidley, D. T., ... Michael, M. (2020). Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 15 (10), 1577-1598. 10.1016/j.jtho.2020.06.021
  • Worth, P. J., Leal, J., Ding, Q., Trickey, A., Dua, M. M., Chatzizacharias, N., ... Hansen, P. (2020). Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions. HPB : the official journal of the International Hepato Pancreato Biliary Association, 22 (9), 1359-1367. 10.1016/j.hpb.2019.12.014
  • Boons, G., Vandamme, T., Ibrahim, J., Roeyen, G., Driessen, A., Peeters, D., ... Van Camp, G. (2020). PDX1DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis. CANCERS, 12 (6)10.3390/cancers12061461
    Other University of Auckland co-authors: Cristin Print
  • Pavlakis, N., Ransom, D. T., Wyld, D., Sjoquist, K. M., Asher, R., Gebski, V., ... Macdonald, W. (2020). Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: Phase II study evaluating the activity of Lu-177-Octreotate peptide receptor radionuclide therapy (LuTate PRRT) and capecitabine, temozolomide CAPTEM)-First results for pancreas and updated midgut neuroendocrine tumors (pNETS, mNETS).. JOURNAL OF CLINICAL ONCOLOGY. (pp. 2).
  • Gurney, J. K., Sarfati, D., Lawrence, B., Jackson, C., Findlay, M., & McPherson, K. (2020). Cancer research in the New Zealand context: Challenges and advantages. JOURNAL OF CANCER POLICY, 2310.1016/j.jcpo.2019.100204
    Other University of Auckland co-authors: Michael Findlay
  • Leyden, S., Kolarova, T., Bouvier, C., Caplin, M., Conroy, S., Davies, P., ... Fisher, G. (2020). Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals. International journal of cancer, 146 (5), 1316-1323. 10.1002/ijc.32678
  • Pavlakis, N., Ransom, D. T., Wyld, D., Sjoquist, K. M., Asher, R., Gebski, V., ... Macdonald, W. (2020). First results for Australasian Gastrointestinal Trials Group (AGITG) control net study: Phase II study of 177Lu-octreotate peptide receptor radionuclide therapy (LuTate PRRT) plus /- capecitabine, temozolomide (CAPTEM) for midgut neuroendocrine tumors (mNETs). Paper presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San Francisco, CA. 23 January - 25 January 2020. JOURNAL OF CLINICAL ONCOLOGY. (pp. 2).

Contact details

Primary office location

M&HS BUILDING 505 - Bldg 505
Level 1, Room 101C
New Zealand